At GSK we are committed to operating at the highest standards of corporate governance.
We believe our governance structure underpins our ability to deliver the Group's strategy to grow a diversified business, deliver more products of value and simplify the operating model.
This section provides information on how GSK is governed, including details on our Board committees and non-Board committees, shareholder information and services, global compliance, ethical conduct, and contact details for our UK and US offices.
To learn more about our behaviour, visit our Responsible Business Supplement 2016.
More about governance
Discover the details of our other specific committees, such as the Disclosure Committee, who sits on them and what they do
Information on reporting to shareholders, such as financial results which are announced on a quarterly basis in April, July, October and February
Sarbanes-Oxley Act 2002
The Sarbanes-Oxley Act of 2002 established new standards for corporate accountability in the USA. Find out how GSK ensures compliance with the Sarbanes-Oxley
Global Ethics and Compliance
The Global Compliance function is responsible for supporting the development and implementation of practices that comply with laws and Group policy
Policies, codes and standards
Find out more about us
What we do
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare
Our mission and strategy
The business is focused around our strategic priorities and our mission is to help people do more, feel better, live longer
Responsible business is how we do business. Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer
Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting